Clinical Trials Browser

INDUSTRY × Solid Tumors × tivozanib × Clear all

NCT01369433 2020-09-01

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Phase NA Terminated

225 enrolled 7 charts

Other solid neoplasm

Solid Tumors

NCT00970411 2017-01-05

Study of KRN951 in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors